Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
Abbott announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular ...
These articles also appear in the Global Biodefense Magazine – 24 March 2020 edition.
Abbott announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular ...
We currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies, of critical importance to determine seroprevalence in a given ...
Regeneron Pharmaceuticals, Inc. today announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that ...
Identifying the closest viral relatives of SARS-CoV-2 circulating in animals will greatly assist studies of viral function. The genomic features ...
The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, ...
PharmaJet has announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of ...
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of ...
Molecular diagnostics company Co-Diagnostics, Inc. announced today that a new FDA policy released last night aimed at expediting the availability ...
A universal flu vaccine has eluded scientists for decades. Unlike other viruses, influenza has a rapid-fire mutation rate and thousands ...
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. Pfizer Inc. and BioNTech SE today announced ...
The FDA today took unprecedented measures to expand coronavirus disease 2019 (COVID-19) diagnostics testing capacity by modifying policy originally issued on Feb. ...
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is ...
Women in Global Health (WGH), and Women of Color Advancing Peace and Security (WCAPS) have partnered to crowdsource a list ...
BD and BioGX Inc today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and ...
U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, ...
On January 20, the World Health Organization (WHO) declared the spread of COVID-19, the disease caused by the new coronavirus ...
Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the first participant ...
It’s always been a question of when, and not whether, humanity would face another challenge on the scale of the ...
Within two months, SARS-CoV-2, a previously unknown coronavirus, has raced around globe, infecting over a 100,000 people with numbers continuing ...
There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients ...